Document is current
Any future updates will be listed below
-
Authors
Wang, Wen
Mai, Jiajia
Hou, Jinlin
Xu, Zhongyuan
Yu, Xian
Ren, Hong
Liang, Xieer
Yang, Yi
Liu, Zhihong
Zhang, Hong
Zhong, Shan
Wen, Yilei
Lu, Tingting
Cao, Haixia
Qiu, Xiao
Wang, Lidan
Zhao, Di
Wang, Miao
Yang, Chengyong
Cheng, Guofeng
Niu, Junqi
Ding, Yanhua
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct06115993 at ClinicalTrials.govDocuments that mention this clinical trial
Safety, pharmacokinetics and antiviral activity of AHB‑137 in healthy volunteers and chronic hepatitis B patients: a phase 1a/1b study
https://doi.org/10.1007/s12072-026-11102-7
-
Funding
Funding for this research was provided by:
AusperBio Therapeutics, Inc.
Ausper Biopharma Co., Ltd.
- License Information
-
More Information
Article History
Received: 14 February 2026
Accepted: 1 May 2026
First Online: 23 May 2026
Declarations
:
: Jinlin Hou is a consultant for and has received grant/research support from Aligos, Gilead Sciences, GlaxoSmithKline, F. Hoffmann-La Roche, Hepa Sera. Authors affiliated with Ausper Biopharma or AusperBio are employees of the sponsor. The remaining authors disclose no conflicts.
: The protocol and consent forms were approved by the ethics committees at each participating site. All participants provided written informed consent.
